Literature DB >> 17448680

Bladder cancer in perfluorooctanesulfonyl fluoride manufacturing workers.

Bruce H Alexander1, Geary W Olsen.   

Abstract

PURPOSE: To determine whether bladder cancer is associated with exposure to perfluorooctane sulfonate (PFOS) in an occupational cohort.
METHODS: Incidence of bladder cancer was ascertained by postal questionnaire to all living current and former employees of the facility (N = 1895) and death certificates for deceased workers (N = 188). Exposure to PFOS was estimated with work history records and weighted with biological monitoring data. Standardized incidence ratios (SIRs) were estimated using U.S. population-based rates as a reference. Bladder cancer risk within the cohort was evaluated using Poisson regression by cumulative PFOS exposure.
RESULTS: Questionnaires were returned by 1,400 of the 1895 cohort members presumed alive. Eleven cases of primary bladder cancer were identified from the surveys (n = 6) and death certificates (n = 5). The SIRs were 1.28 (95% confidence interval [CI] = 0.64-2.29) for the entire cohort and 1.74 (95% CI = 0.64-3.79) for those ever working in a high exposed job. Compared with employees in the lowest cumulative exposure category, the relative risk of bladder cancer was 0.83 (95% CI = 0.15-4.65), 1.92 (95% CI = 0.30-12.06), and 1.52 (95% CI = 0.21-10.99).
CONCLUSIONS: The results offer little support for an association between bladder cancer and PFOS exposure, but the limited size of the population prohibits a conclusive exposure response analysis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448680     DOI: 10.1016/j.annepidem.2007.01.036

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  17 in total

1.  Changing interpretation of human health risks from perfluorinated compounds.

Authors:  Philippe Grandjean; Richard Clapp
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

Review 2.  Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Authors:  Emanuela Corsini; Robert W Luebke; Dori R Germolec; Jamie C DeWitt
Journal:  Toxicol Lett       Date:  2014-02-03       Impact factor: 4.372

3.  Perfluorooctanoic acid (PFOA) acts as a tumor promoter on Syrian hamster embryo (SHE) cells.

Authors:  N Jacquet; M A Maire; C Rast; M Bonnard; P Vasseur
Journal:  Environ Sci Pollut Res Int       Date:  2012-08-31       Impact factor: 4.223

4.  Exposure to perfluorinated compounds: in vitro study on thyroid cells.

Authors:  Francesca Coperchini; Patrizia Pignatti; Serena Lacerenza; Sara Negri; Riccardo Sideri; Claudia Testoni; Luca de Martinis; Danilo Cottica; Flavia Magri; Marcello Imbriani; Mario Rotondi; Luca Chiovato
Journal:  Environ Sci Pollut Res Int       Date:  2014-09-04       Impact factor: 4.223

5.  Using blood gene signatures for assessing effects of exposure to perfluoroalkyl acids (PFAAs) in humans: the NOWAC postgenome study.

Authors:  Charlotta Rylander; Vanessa Dumeaux; Karina Standahl Olsen; Marit Waaseth; Torkjel M Sandanger; Eiliv Lund
Journal:  Int J Mol Epidemiol Genet       Date:  2011-06-03

Review 6.  Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Authors:  F Coperchini; O Awwad; M Rotondi; F Santini; M Imbriani; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-11-11       Impact factor: 4.256

7.  Per- and polyfluoroalkyl substances in human serum and urine samples from a residentially exposed community.

Authors:  Rachel Rogers Worley; Susan McAfee Moore; Bruce C Tierney; Xiaoyun Ye; Antonia M Calafat; Sean Campbell; Million B Woudneh; Jeffrey Fisher
Journal:  Environ Int       Date:  2017-06-20       Impact factor: 9.621

8.  Dietary predictors and plasma concentrations of perfluorinated compounds in a coastal population from northern Norway.

Authors:  Charlotta Rylander; Magritt Brustad; Helena Falk; Torkjel M Sandanger
Journal:  J Environ Public Health       Date:  2010-01-06

9.  Early life exposure to per- and polyfluoroalkyl substances and mid-childhood lipid and alanine aminotransferase levels.

Authors:  Ana M Mora; Abby F Fleisch; Sheryl L Rifas-Shiman; Jennifer A Woo Baidal; Larissa Pardo; Thomas F Webster; Antonia M Calafat; Xiaoyun Ye; Emily Oken; Sharon K Sagiv
Journal:  Environ Int       Date:  2017-11-20       Impact factor: 9.621

Review 10.  PFAS and cancer, a scoping review of the epidemiologic evidence.

Authors:  Kyle Steenland; Andrea Winquist
Journal:  Environ Res       Date:  2020-12-30       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.